SCHEMBL10195291

SCHEMBL10195291

CCc1ccc(Oc2nc3ccc(C)cc3s2)cc1C1=C(O)C(C)(C)OC(C)(C)C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.34
PTPN1 P18031 1/20 0.34
NPC1 O15118 4/20 0.33
RAB9A P51151 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
TP53 P04637 3/20 0.33
ALDH1A1 P00352 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 5/20 0.32
LTA4H P09960 1/20 0.32
GAA P10253 1/20 0.32
CYP2C19 P33261 1/20 0.32
DYRK1A Q13627 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
RXFP1 Q9HBX9 1/20 0.31
RORC P51449 1/20 0.31
CSNK1D P48730 1/20 0.31
CASP3 P42574 1/20 0.31
SENP8 Q96LD8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10195359 0.91 ATAD2 (0.38) NPC1RAB9ASMN1; SMN2TP53ALDH1A1
SCHEMBL10195210 0.90 KMT2A (0.35) EPHX2PTPN1NPC1RAB9ATP53
SCHEMBL10195356 0.90 EPHX2 (0.33) EPHX2RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL10195209 0.89 CYP1A2 (0.42) EPHX2SMN1; SMN2LTA4HCYP2C19
SCHEMBL10195366 0.88 EPHX2 (0.45) EPHX2MAPTDYRK1ACSNK1D
SCHEMBL16351646 0.88 KMT2A (0.39) PTPN1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL10195365 0.88 DYRK1A (0.39) EPHX2NPC1RAB9ASMN1; SMN2TP53
SCHEMBL10195363 0.86 NPC1 (0.38) EPHX2NPC1RAB9ASMN1; SMN2TP53
SCHEMBL10195360 0.85 L3MBTL1 (0.37) NPC1RAB9ASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL10195386 0.85 CTSD (0.34) EPHX2SMN1; SMN2L3MBTL1LTA4HGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 EPHX2 54/4885PTPN1 227/4885NPC1 4365/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 EPHX2 154/4885PTPN1 374/4885NPC1 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.